BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 22548832)

  • 1. T1 mapping of the myocardium: intra-individual assessment of the effect of field strength, cardiac cycle and variation by myocardial region.
    Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 May; 14(1):27. PubMed ID: 22548832
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T1 mapping of the myocardium: intra-individual assessment of post-contrast T1 time evolution and extracellular volume fraction at 3T for Gd-DTPA and Gd-BOPTA.
    Kawel N; Nacif M; Zavodni A; Jones J; Liu S; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Apr; 14(1):26. PubMed ID: 22540153
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low dose gadobenate dimeglumine for imaging of chronic myocardial infarction in comparison with standard dose gadopentetate dimeglumine.
    Bauner KU; Reiser MF; Huber AM
    Invest Radiol; 2009 Feb; 44(2):95-104. PubMed ID: 19077911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diffuse myocardial fibrosis evaluation using cardiac magnetic resonance T1 mapping: sample size considerations for clinical trials.
    Liu S; Han J; Nacif MS; Jones J; Kawel N; Kellman P; Sibley CT; Bluemke DA
    J Cardiovasc Magn Reson; 2012 Dec; 14(1):90. PubMed ID: 23272704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Partition coefficients for gadolinium chelates in the normal myocardium: comparison of gadopentetate dimeglumine and gadobenate dimeglumine.
    Kawel N; Nacif M; Santini F; Liu S; Bremerich J; Arai AE; Bluemke DA
    J Magn Reson Imaging; 2012 Sep; 36(3):733-7. PubMed ID: 22488770
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Assessment of diffuse myocardial fibrosis in rats using small-animal Look-Locker inversion recovery T1 mapping.
    Messroghli DR; Nordmeyer S; Dietrich T; Dirsch O; Kaschina E; Savvatis K; O h-Ici D; Klein C; Berger F; Kuehne T
    Circ Cardiovasc Imaging; 2011 Nov; 4(6):636-40. PubMed ID: 21917782
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T
    Maforo NG; Magrath P; Moulin K; Shao J; Kim GH; Prosper A; Renella P; Wu HH; Halnon N; Ennis DB
    J Cardiovasc Magn Reson; 2020 Dec; 22(1):85. PubMed ID: 33302967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparison of acquisition time and dose for late gadolinium enhancement imaging at 3.0 T in patients with chronic myocardial infarction using Gd-BOPTA.
    Doltra A; Skorin A; Hamdan A; Schnackenburg B; Gebker R; Klein C; Nagel E; Fleck E; Kelle S
    Eur Radiol; 2014 Sep; 24(9):2192-200. PubMed ID: 24828537
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique.
    White SK; Sado DM; Fontana M; Banypersad SM; Maestrini V; Flett AS; Piechnik SK; Robson MD; Hausenloy DJ; Sheikh AM; Hawkins PN; Moon JC
    JACC Cardiovasc Imaging; 2013 Sep; 6(9):955-62. PubMed ID: 23582361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Systolic MOLLI T1 mapping with heart-rate-dependent pulse sequence sampling scheme is feasible in patients with atrial fibrillation.
    Zhao L; Li S; Ma X; Greiser A; Zhang T; An J; Bai R; Dong J; Fan Z
    J Cardiovasc Magn Reson; 2016 Mar; 18():13. PubMed ID: 26980571
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Histological Validation of measurement of diffuse interstitial myocardial fibrosis by myocardial extravascular volume fraction from Modified Look-Locker imaging (MOLLI) T1 mapping at 3 T.
    de Meester de Ravenstein C; Bouzin C; Lazam S; Boulif J; Amzulescu M; Melchior J; Pasquet A; Vancraeynest D; Pouleur AC; Vanoverschelde JL; Gerber BL
    J Cardiovasc Magn Reson; 2015 Jun; 17(1):48. PubMed ID: 26062931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive validation of cardiovascular magnetic resonance techniques for the assessment of myocardial extracellular volume.
    Miller CA; Naish JH; Bishop P; Coutts G; Clark D; Zhao S; Ray SG; Yonan N; Williams SG; Flett AS; Moon JC; Greiser A; Parker GJ; Schmitt M
    Circ Cardiovasc Imaging; 2013 May; 6(3):373-83. PubMed ID: 23553570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of age-related interstitial myocardial fibrosis with cardiac magnetic resonance contrast-enhanced T1 mapping: MESA (Multi-Ethnic Study of Atherosclerosis).
    Liu CY; Liu YC; Wu C; Armstrong A; Volpe GJ; van der Geest RJ; Liu Y; Hundley WG; Gomes AS; Liu S; Nacif M; Bluemke DA; Lima JAC
    J Am Coll Cardiol; 2013 Oct; 62(14):1280-1287. PubMed ID: 23871886
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T1 contrast in the myocardium and blood pool: a quantitative assessment of gadopentetate dimeglumine and gadofosveset trisodium at 1.5 and 3 T.
    Lin K; Lloyd-Jones DM; Spottiswoode B; Bi X; Liu Y; Lu B; Xue H; Wang Y; Li D; Carr JC
    Invest Radiol; 2014 Apr; 49(4):243-8. PubMed ID: 24473364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assessment of nonischemic fibrosis in hypertrophic cardiomyopathy: comparison of gadopentetate dimeglumine and gadobenate dimeglumine for enhanced cardiovascular magnetic resonance imaging.
    Rudolph A; von Knobelsdorff-Brenkenhoff F; Wassmuth R; Prothmann M; Utz W; Schulz-Menger J
    J Magn Reson Imaging; 2014 May; 39(5):1153-60. PubMed ID: 24151119
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions.
    Neilan TG; Coelho-Filho OR; Shah RV; Abbasi SA; Heydari B; Watanabe E; Chen Y; Mandry D; Pierre-Mongeon F; Blankstein R; Kwong RY; Jerosch-Herold M
    JACC Cardiovasc Imaging; 2013 Jun; 6(6):672-83. PubMed ID: 23643283
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gd-BOPTA for assessment of myocardial viability on MRI: changes of T1 value and their impact on delayed enhancement.
    Krombach GA; Hahnen C; Lodemann KP; Krämer N; Schoth F; Neizel M; Boeringer J; Günther RW; Kelm M; Kühl H
    Eur Radiol; 2009 Sep; 19(9):2136-46. PubMed ID: 19373470
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myocardial T
    Weingärtner S; Meßner NM; Budjan J; Loßnitzer D; Mattler U; Papavassiliu T; Zöllner FG; Schad LR
    J Cardiovasc Magn Reson; 2016 Nov; 18(1):84. PubMed ID: 27855705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. T1 and T2 mapping cardiovascular magnetic resonance imaging techniques reveal unapparent myocardial injury in patients with myocarditis.
    Radunski UK; Lund GK; Säring D; Bohnen S; Stehning C; Schnackenburg B; Avanesov M; Tahir E; Adam G; Blankenberg S; Muellerleile K
    Clin Res Cardiol; 2017 Jan; 106(1):10-17. PubMed ID: 27388331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual comparison of T1 relaxation times after gadobutrol and Gd-DTPA administration for cardiac late enhancement imaging.
    Doeblin P; Schilling R; Wagner M; Luhur R; Huppertz A; Hamm B; Taupitz M; Durmus T
    Eur J Radiol; 2014 Apr; 83(4):660-4. PubMed ID: 24433640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.